Updated on 19 August 2026
Expertise in Cancer Biology, Molecular Targets and Innovative Therapeutic Approaches
Lab Head at Institute of Biochemistry named after H Buniatian
Yerevan, Armenia
About
What we offer:
The H. Buniatian Institute of Biochemistry, NAS RA, offers expertise in molecular biochemistry, pharmacology, cancer-related molecular mechanisms, and translational biomedical research. Our research includes investigation of PRPS-1 as a potential molecular target in glioma and development of innovative approaches for cancer diagnosis and therapy.
We also have expertise in bioactive compounds, protein- and peptide-based approaches, oxidative stress, molecular mechanisms of cell proliferation, and experimental evaluation of therapeutic strategies.
What we are looking for:
We are seeking European research institutions, universities, hospitals, biotechnology and pharmaceutical companies interested in collaborative cancer research, particularly in molecular targets, glioma/glioblastoma, biomarker discovery, innovative therapeutics, and translational research.
Potential role:
Research partner contributing biochemical, pharmacological and preclinical expertise to Horizon Europe consortia and collaborative projects.
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Translational Cancer Research & Precision Therapeutics
- Partner seeks Consortium/Coordinator
Kristine Danielyan
Lab Head at Institute of Biochemistry named after H Buniatian
Yerevan, Armenia
Project cooperation
Cancer Researcher : Prostate Cancer & Epigenetics
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
EFTHALIA KONTOGIANNI
Biologist, MSc, First stage researcher at Department of Pathology, University of Patras
Patras, Greece
Project cooperation
Patient-Derived Xenograft (PDX) Models for Translational Cancer Research
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
Susan (Souzana) Logotheti
Lecturer at University of Patras, Greece
Patras, Greece